Chemical Structure (Esbriet 01)
Esbriet Tablet, Coated
Product Images NDC 83107-028
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esbriet (NDC 83107-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Legacy Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Esbriet 02)
This description provides numeric data related to the change in %FVC (Forced Vital Capacity) over time for two groups: the ESBRIET group (n=278) and the Placebo group (n=277). The data includes percentages such as 100%, 80%, 70%, and other varying values from -10 to 30%, representing the changes in %FVC from baseline to week 52 for the groups. The chart shows the absolute change in %FVC for both groups, indicating whether there was a worsening or no decline over the specified time period.*
Figure 2 (Esbriet 03)
Figure 3 (Esbriet 04)
This is a clinical trial report showing the percentage of patients alive over time for patients taking Esbriet (pirfenidone) compared to a placebo. The hazard ratio (HR) with a 95% confidence interval is reported as 0.75 (0.51-1.11). The number of patients at risk over weeks is also provided.*
Image Description (Esbriet 06a)
Image Description (Esbriet 07a)
This text provides information about a medication known as Esbriet (pirfenidone), consisting of 90 tablets. The dosage details are not available in the text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
